Literature DB >> 2456999

Postoperative reduction of serum beta-HCG in testicular seminoma.

S Sakashita1, T Demura, T Gotoh, A Maru, T Koyanagi.   

Abstract

Serum beta-HCG and urinary HCG were measured in 17 patients with histologically proved pure seminoma of the testis. The patients have been followed to date for 10 to 74 months after orchiectomy, and have no residual disease or recurrence of their disease. Preoperative urinary HCG levels were abnormal in 9 patients (53%). Serum beta-HCG levels were slightly elevated in 6 out of 12 patients evaluated, and were reduced after orchiectomy even in patients with preoperative normal beta-HCG levels (P less than 0.05). Preoperative levels of the tumour marker in seminoma were far lower than in patients with non-seminomatous germ cell tumours, but it would not be rare to see a small amount of HCG produced by the tumour cells in the seminoma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456999     DOI: 10.1007/bf02549517

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  11 in total

Review 1.  Gonadotropins and their subunits: basic and clinical studies.

Authors:  J L Vaitukaitis; G T Ross; G D Braunstein; P L Rayford
Journal:  Recent Prog Horm Res       Date:  1976

2.  The endocrinology of human chorionic gonadotropin-secreting testicular tumors: new methods in diagnosis.

Authors:  J S Cochran; P C Walsh; J C Porter; T C Nicholson; J D Madden; P C Peters
Journal:  J Urol       Date:  1975-10       Impact factor: 7.450

3.  Should an elevated human chorionic gonadotropin titer alter therapy for seminoma?

Authors:  D A Swartz; D E Johnson; D H Hussey
Journal:  J Urol       Date:  1984-01       Impact factor: 7.450

4.  Possible new approaches to the management of seminoma of the testis.

Authors:  R T Oliver; H F Hope-Stone; J P Blandy
Journal:  Br J Urol       Date:  1984-12

5.  Experience with beta-HCG-positive seminoma.

Authors:  W Kuber; C Kratzik; H P Schwarz; M Susani; J Spona
Journal:  Br J Urol       Date:  1983-10

6.  Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.

Authors:  P H Lange; L E Nochomovitz; J Rosai; E E Fraley; B J Kennedy; G Bosl; J Brisbane; W J Catalona; J S Cochran; R H Comisarow; K B Cummings; J B deKernion; L H Einhorn; T R Hakala; M Jewett; M R Moore; P T Scardino; J M Streitz
Journal:  J Urol       Date:  1980-10       Impact factor: 7.450

7.  Chemotherapy of disseminated testicular cancer. A random prospective study.

Authors:  L H Einhorn; S D Williams
Journal:  Cancer       Date:  1980-09-15       Impact factor: 6.860

8.  Falsely positive specific human chorionic gonadotropin assays in patients with testicular tumors: conversion to negative with testosterone administration.

Authors:  W J Catalona; J L Vaitukaitis; W R Fair
Journal:  J Urol       Date:  1979-07       Impact factor: 7.450

9.  Errors in measurement and reporting of serum markers in patients with germ cell tumors.

Authors:  F M Kardon; J G Krikorian; J A Lopez; R D White
Journal:  Urology       Date:  1982-11       Impact factor: 2.649

10.  Flow cytometric evaluation of sperm from patients with testicular carcinoma.

Authors:  D P Evenson; F A Klein; W F Whitmore; M R Melamed
Journal:  J Urol       Date:  1984-12       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.